NID1 and central nervous system cancer: We have found that overexpression of miR-1298-3p downregulates the levels of NID1 and vimentin, and upregulates the level of E-cadherin in glioma cells, indicating that overexpression of miR-1298-3p inhibits glioma cell invasion.